Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DEBRA L BUTLER

Allopathic & Osteopathic Physicians Radiology Diagnostic Radiology

NPI
1336141829
CMS profile
458207
Location
HOUSTON, TX

General Payments · PY2020–2024

$259,112.70

  • Reported across 156 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$56,330.92

31 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $55,623.41 23
Travel and Lodging $621.10 6
Food and Beverage $86.41 2

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $56,330.92 31

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $2,352.63 4
PY2021 $35,941.42 24
PY2022 $74,962.43 37
PY2023 $89,525.30 60
PY2024 $56,330.92 31

Payment records · PY2024 (31)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 01/15/2024 Consulting Fee Undisputed 01/23/2026 1137500247 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 01/15/2024 Consulting Fee Undisputed 01/23/2026 1137500251 CMS
Takeda Pharmaceuticals U.S.A., Inc. $102.59 01/15/2024 Travel and Lodging Undisputed 01/23/2026 1137500254 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.30 01/15/2024 Travel and Lodging Undisputed 01/23/2026 1137500258 CMS
Takeda Pharmaceuticals U.S.A., Inc. $60.00 01/15/2024 Travel and Lodging Undisputed 01/23/2026 1137500262 CMS
Takeda Pharmaceuticals U.S.A., Inc. $40.36 01/15/2024 Food and Beverage Undisputed 01/23/2026 1137500266 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137500269 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 02/02/2024 Consulting Fee Undisputed 01/23/2026 1137500273 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137500277 CMS
Takeda Pharmaceuticals U.S.A., Inc. $347.25 02/16/2024 Travel and Lodging Undisputed 01/23/2026 1137500281 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,000.00 02/23/2024 Consulting Fee Undisputed 01/23/2026 1137500284 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 02/23/2024 Consulting Fee Undisputed 01/23/2026 1137500288 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137500292 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 03/18/2024 Consulting Fee Undisputed 01/23/2026 1137500296 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 04/08/2024 Consulting Fee Undisputed 01/23/2026 1137500299 CMS
Takeda Pharmaceuticals U.S.A., Inc. $30.00 04/08/2024 Travel and Lodging Undisputed 01/23/2026 1137500303 CMS
Takeda Pharmaceuticals U.S.A., Inc. $46.05 04/08/2024 Food and Beverage Undisputed 01/23/2026 1137500307 CMS
Takeda Pharmaceuticals U.S.A., Inc. $65.96 04/08/2024 Travel and Lodging Undisputed 01/23/2026 1137500310 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137500314 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137500318 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137500322 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 05/17/2024 Consulting Fee Undisputed 01/23/2026 1137500325 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137500329 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 06/14/2024 Consulting Fee Undisputed 01/23/2026 1137500333 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,263.34 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137500337 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137500340 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137500344 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,526.67 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137500348 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,626.67 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137500352 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,626.67 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137500356 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,626.67 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137500359 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.